Your browser doesn't support javascript.
loading
Efectos de la infusión aguda de octreotido sobre la función renal en pacientes con cirrosis hepática e hipertensión portal / Effects of acute octreotide infusion on renal function in patients with cirrhosis and portal hypertension
Silva P, Guillermo; Segovia M, Roberto; Backhouse E, Claudia; Palma, Mariana; Márquez, Sylvia; Iturriaga R, Hernán.
  • Silva P, Guillermo; Clínica Las Condes. Departamento de Gastroenterología. Santiago. CL
  • Segovia M, Roberto; Clínica Las Condes. Departamento de Gastroenterología. Santiago. CL
  • Backhouse E, Claudia; Universidad de Chile. Facultad de Medicina. Departamento de Medicina. Unidad de Gastroenterología. CL
  • Palma, Mariana; Hospital Clínico San Borja-Arriarán. Instituto Chileno-JaponÚs de Enfermedades Digestivas. Santiago. CL
  • Márquez, Sylvia; Hospital Clínico San Borja-Arriarán. Instituto Chileno-JaponÚs de Enfermedades Digestivas. Santiago. CL
  • Iturriaga R, Hernán; Hospital Clínico San Borja-Arriarán. Instituto Chileno-JaponÚs de Enfermedades Digestivas. Santiago. CL
Rev. méd. Chile ; 132(2): 144-150, feb. 2004. ilus, tab
Artículo en Español | LILACS | ID: lil-361489
RESUMO

Background:

Octreotide is used in the treatment of acute variceal bleeding, based on its inhibitory effects of post-prandial splanchnic hyperemia and splanchnic venoconstriction. The consequences of these haemodynamic changes on renal circulation are not well known in cirrhotic patients.

Aim:

To evaluate the effects of acute octreotide administration on several parameters of renal function, including free water clearance, in patients with cirrhosis with or without ascites. Patients and

Methods:

Twenty cirrhotic patients, Child-Pugh A or B, with or without ascites, with esophageal varices, normal renal function and free of medications (vasoactive drugs or diuretics) were assigned to 2 different protocols. Protocol 1 10 patients were randomized to receive octreotide or placebo, as a bolus followed by a continuous infusion. Glomerular filtration rate (GFR) and renal plasma flow (PRF) were measured, in basal conditions and during the drug or placebo administration. Protocol 2 10 additional patients were randomized in the same way and free water clearance and urinary sodium excretion were again measured in the basal period and during the drug or placebo infusion.

Results:

After octreotide or placebo administration no significant changes were observed neither in GFR nor in PRF. The free water clearance decreased significantly during octreotide administration (3.12 ml/min±1.04 SE vs 0.88±0.39, p <.03). In both protocols no changes in mean arterial pressure were observed.

Conclusions:

Acute administration of octreotide to cirrhotic patients with portal hypertension, with or without ascites, did not produce any change in glomerular filtration rate or in estimated renal plasma blood flow. However the free water clearance decreased significantly. This effect, under chronic administration, could be clinically important and deserves further studies.
Asunto(s)
Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Octreótido / Pruebas de Función Renal Tipo de estudio: Ensayo Clínico Controlado / Guía de Práctica Clínica Límite: Femenino / Humanos / Masculino Idioma: Español Revista: Rev. méd. Chile Asunto de la revista: Medicina Año: 2004 Tipo del documento: Artículo País de afiliación: Chile Institución/País de afiliación: Clínica Las Condes/CL / Hospital Clínico San Borja-Arriarán/CL / Universidad de Chile/CL

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Octreótido / Pruebas de Función Renal Tipo de estudio: Ensayo Clínico Controlado / Guía de Práctica Clínica Límite: Femenino / Humanos / Masculino Idioma: Español Revista: Rev. méd. Chile Asunto de la revista: Medicina Año: 2004 Tipo del documento: Artículo País de afiliación: Chile Institución/País de afiliación: Clínica Las Condes/CL / Hospital Clínico San Borja-Arriarán/CL / Universidad de Chile/CL